-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
▎Edited by WuXi AppTec Content Team
Amyotrophic lateral sclerosis (ALS) or commonly known as "ALS" is the most common motor neuron disease (MND), affecting 2.One of the reasons that ALS is difficult to treat is the heterogeneity of genetic variation among patients, which means that genetic variation among different ALS patients is very different, so there is no suitable common target for drug development
▲ Molecular formula of Terazosin (Image source: Fvasconcellos, Public domain, via Wikimedia Commons)
WuXi AppTec provides integrated, end-to-end new drug R&D and production services for the global biopharmaceutical industry, covering chemical drug R&D and production, biological research, preclinical testing and clinical trial R&D, cell and gene therapy R&D, testing and production and other fields